As of 2025-09-18, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 2.13 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 57.7%.
The range of the Relative Valuation is 1.97 - 2.29 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.5x - 1.7x | 1.6x |
| Forward P/E multiples | 1.5x - 1.7x | 1.6x |
| Fair Price | 1.97 - 2.29 | 2.13 |
| Upside | 45.9% - 69.5% | 57.7% |
| Date | P/E |